Clinical trial
Albright Hereditary Osteodystrophy: Natural History, Growth, and…
NCT00209235 · Connecticut Children's Medical Center, Other · Recruiting
Key facts
| NCT number | NCT00209235 |
|---|---|
| Title | Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments |
| Official title | Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy |
| Lead sponsor | Connecticut Children's Medical Center, Other |
| Collaborators | Johns Hopkins University Hugo W. Moser Research Institute at Kennedy Krieger, Inc. UConn Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Pseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy, Pseudopseudohypoparathyroidism |
| Intervention type | Behavioral |
| Interventions | Neurocognitive and psychosocial testing |
| Enrollment | 600 |
| Start date | Jan 1, 2003 |
| Primary completion | Oct 1, 2030 |
| Completion | Dec 1, 2030 |
| First posted | Sep 21, 2005 |
| Last update posted | May 28, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: